Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1300087	重组抗TNFα全人单克隆抗体注射液	adalimumab	Injection	Biological Products(2)	New Drug Application	2013-12-02	齐鲁制药有限公司	QILU Pharmaceutical Co Ltd	Certificate Issued	2016-06-27	view
CXSL1300088	重组抗TNFα全人单克隆抗体注射液	adalimumab	Injection	Biological Products(2)	New Drug Application	2013-12-11	齐鲁制药有限公司	QILU Pharmaceutical Co Ltd	Certificate Issued	2016-06-27	view
CXSL1300056	重组抗TNFα全人单克隆抗体注射液	adalimumab	Injection	Biological Products(2)	New Drug Application	2013-12-23	上海复宏汉霖生物技术有限公司	Shanghai Henlius Biotech Co Ltd	Certificate Issued	2016-01-14	view
CXSL1600095	重组抗TNFα全人单克隆抗体注射液	adalimumab	Injection	Biological Products(2)	New Drug Application	2016-12-12	上海复宏汉霖生物技术有限公司	Shanghai Henlius Biotech Co Ltd	Certificate Issued	2017-04-20	view